Last updated at 06 Jul 2024 04:30 AM
Director
DIN: 03050225
Aparna Tyagi is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at INVENTA ORGANICS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03050225.Aparna Tyagi has previously been associated with 2 companies in roles such as Additional Director.Aparna Tyagi is currently involved in 2 different roles. Their most recent position is with HEALTHRAYS MEDICARE LLP as a Designated Partner. The first company Aparna Tyagi was appointed to as a director was INVENTA ORGANICS PRIVATE LIMITED. Aparna Tyagi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Aparna Tyagi is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at INVENTA ORGANICS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03050225.Aparna Tyagi has previously been associated with 2 companies in roles such as Additional Director.Aparna Tyagi is currently involved in 2 different roles. Their most recent position is with HEALTHRAYS MEDICARE LLP as a Designated Partner. The first company Aparna Tyagi was appointed to as a director was INVENTA ORGANICS PRIVATE LIMITED. Aparna Tyagi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (2)
3y 2m 1y 7m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| INVENTA ORGANICS PRIVATE LIMITED | Director | 29-Sep-2012 |
| MEDMONKS MEDICARE PRIVATE LIMITED | Director | 10-Feb-2021 |